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1. Introduction 
Yeast mitochondrial protein synthesis is normally 
sensitive to a wide spectrum of antibiotics effective 
on bacterial ribosomes [ 1,2]. Mutant strains, resistant 
to one or several of these antibiotics have been isolated 
[3] and in some of these mutants resistance is inherited 
cytoplasmically [4-81, implying that mitochondrial 
DNA specifies the component changed. Such mutants, 
therefore, provide a promising approach for the iden- 
tification of mitochondrial genes. 
Bunn et al. [9] have shown that two types of 
cytoplasmic mutants can be distinguished. The first 
type is isolated as resistant to mikamycin, but is cross- 
resistant to several other unrelated antibiotics. The 
mitochondria of this class of mutants lose resistance 
to the antibiotics on isolation. They are therefore 
thought to possess an altered inner membrane, imper- 
meable to the antibiotics in vivo, but made leaky by 
the process of isolation. The second type of mutant 
is isolated as resistant to erythromycin, but often 
shows cross-resistance to several macrolides and lin- 
comycin [S, 71, a phenomenon also observed for some 
bacteria [lo] . Mitochondria isolated from these 
mutants retain resistance in vitro, even if the mito- 
chondrial membrane is damaged by freezing and 
thawing and this led Linnane et al. [5] to propose 
that resistance in these mutants is due to an altered 
mitochondrial ribosome. This experiment is not con- 
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elusive, however, because amino acid incorporation 
of frozen-thawed mitochondria is very low (cf. [5] ) 
and this low residual activity could merely reflect the 
presence of intact organelles remaining after the 
treatment rather than the presence of resistant ribo- 
somes. Unambiguous proof that the ribosome itself is 
changed requires, therefore, the isolation of mito- 
chondrial ribosomes with good catalytic activity. 
We have recently succeeded in isolating mitochon- 
drial ribosomes from yeast that are highly active in 
catalyzing poly U-directed polyphenylalanine syn- 
thesis [l l] . Using such ribosomes, we show in this 
paper that resistance to erythromycin in mutant 
6-8 1 c is due to a change, not in the mitochondrial 
membrane, but in the mitochondrial ribosome itself. 
2. Methods and materials 
6-8 1 c , a strain of Saccharomyces cerevisiae 
isolated as a spontaneous cytoplasmic mutant resistant 
to greater than 4 mg/ml erythromycin (cf. [7]) was, 
together with the wild-type strain D-6 arg me, gene- 
rously donated by Drs. Thomas and Wilkie**. Yeast 
was grown and mitochondria were prepared essential- 
ly according to the method of Ohnishi, Kawaguchi 
and Hagihara [ 121 . A four-times washed mitochondri- 
al fraction (cf. [ 131) was lysed in 50 mM NH&l, 10 
mM magnesium acetate, 10 mM tris-Cl (pH 7.5), 6 
mM 2-mercaptoethanol (AMT), containing 0.3% 
** Present address: National Institute for Medical Research, 
Mill Hill, London, and Department of Botany, University 
College, London. 
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sodium deoxycholate and ribosomes were isolated 
and purified by a method to be described fully else- 
where [14]. 
Assay of amino acid incorporation by intact mito- 
chondria in vitro was as described by Grivell [ 151. 
The incubation medium contained mitochondria at a 
final concentration of approximately 1 mg/ml, 150 
mM KCl, 44-60 mM mannitol, 20 mM tris base, 10 
mM KH2PQ4, 10 mM MgCls , 5 mM 2-oxoglutarate, 
2 mM ATP, 2 mg/ml bovine plasma albumin. A further, 
small amount of tris base was used to adjust the 
medium to pH 6.7. 14C-L-Leucine (62 mCi per mmole; 
Radiochemical Centre, Amersham, England) was 16 
PM. Incubation was for 30 min at 30” in a total volume 
of 0.5 ml. 
The measurement of poly U-directed polyphenyl- 
alanine synthesis was carried out as described by 
Hosokawa, Fujimura and Nomura [ 161 in the presence 
of a supernatant fraction prepared from Escherichia 
coli by alumina grinding, centrifugation at 105,000 
g for 4 hr and overnight dialysis versus AMT. The in- 
cubation mixture contained 15 mM magnesium acetate 
(instead of 10 mM), 660 I_(g protein of the supernatant 
fraction per ml; mitochondrial ribosomes corresponding 
to an A,,, nm of 6 per ml and 5 PM r4C-phenylalanine 
(U) (477 mCi per mmole; Radiochemical Centre, 
Amersham, England). 
The peptidyl transferase activity of mitochondrial 
and E. coli ribosomes was assayed at 0” as described 
by De Vries, Agsteribbe and Kroon [17] . The assay 
is a modification of the fragment reaction of Monro, 
Cerna and Marcker [ 181 and uses acetyl ‘H-leucyl- 
tRNA as substrate in place of CACCA-3H-Leu-Ac. 
The specific activity of the 3H4,5-leucine used was 
10 mCi per mmole. 
Ribosomes were prepared from E. coli Q13 as 
described by Nirenberg [ 191. 
Erythromycin base was obtained from Abbott and 
lincomycin hydrochloride monohydrate from Upjohn. 
3. Results 
Growth of strain 6-81~ on glycerol-containing 
media is resistant to concentrations of erythromycin 
greater than 4 mg/ml, while that of the parent strain, 
D-6, is sensitive to less than 100 &/ml (D. Thomas and 
D. Wilkie, personal communication). This difference 
between the strains is also observed when incorporation 
of r4C-leucine by intact mitochondria in vitro is 
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Fig. 1. Effects of erythromycin on protein synthesis by (A) 
intact mitochondria nd (B) isolated mitochondrial ribo- 
somes. The erythromycin-resistant d wild-type strains are 
denoted by 6-81~ and D-6, respectively. 
measured (fig. IA). Similar results have been reported 
for other, independently isolated mutants [.5,7] . 
In order to determine whether resistance was the 
result of a change in the mitochondrial ribosome, 
isolated ribosomes were tested for erythromycin sen- 
sitivity. Mitochondrial ribosomes were combined with 
a supernatant fraction obtained from E. coli (see 
sect. 2) and the effect of erythromycin on poly U- 
directed phenylalanine incorporation was measured. 
The rate of amino acid incorporation in this system 
was 80- 100 pmoles per mg RNA per 30 mm and the 
degree of stimulation by poly U was 20-fold. 
Polyphenylalanine synthesis by ribosomes from 
6-81c, the resistant mutant, was completely insensitive 
to erythromycin (fig. 1B). However, activity of ribo- 
somes from the wild-type strain, D-6, was only slightly 
inhibited even at concentrations of the antibiotic as 
high as 100 pg/ml. A similar insentivity to erythro- 
mycin of poly U-directed incorporation has been 
reported for wild-type ribosomes from E. cob [20] . 
It was clear, therefore, that this system could not 
distinguish in a conclusive manner between antibiotic 
resistant and sensitive ribosomes, even though the dif- 
ference in sensitivity shown in fig. 1 was quite repro- 
ducible in different ribosome preparations. 
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Experiments in which poly A or poly C were used 
as synthetic messenger were also not satisfactory: al- 
though incorporation directed by these polynucleotides 
is highly sensitive to erythromycin when bacterial ribo- 
somes are used, the activity of mitochondrial ribosomes 
was too low with these messengers to permit response 
to antibiotics to be tested reliably. 
Two other approaches were successful, however. 
First, use was made of the observations that resistance 
to many macrolide antibiotics and lincomycin is often 
linked [4,5, lo] and that poly U-directed phenyl- 
alanine incorporation is sensitive to lincomycin [21]. 
Analysis of the response of mitochondria isolated 
from the two strains indeed showed that amino acid 
incorporation by the wild-type strain, D6, was com- 
pletely inhibited by 10m3 M lincomycin, whereas in- 
corporation by mitochondria from the mutant strain, 
6-8 lc, was only partially inhibited (fig. 2A). This dif- 
ference in sensitivity was retained when the isolated 
ribosomes were analysed. Polyphenylalanine synthesis 
by the wild-type ribosomes was totally inhibited by 
lo-’ M lincomycin, but even 10e4 M lincomycin failed 
to inhibit the mutant ribosomes by more than 50% 
(fig. 2B). The -esults strongly suggest hat resistance 
10-6 10-5 10-b lo3 
Lincomycin I M 1 
Fig. 2. Effects of lincomycin on protein synthesis by (A) in- 
tact mitochondria nd (B) isolated mitochondrial ribosomes. 
to erythromycin in strain 6-81~ is associated with a 
change in the mitochondrial ribosome and that this 
change is also involved in determining resistance to 
lincomycin. 
This conclusion was confirmed by direct assay of 
the effects of the two antibiotics on ribosomal pepti- 
dyl transfer, measured by the fragment reaction [ 181. 
This reaction is completely inhibited by chloram- 
phenicol, but not by many macrolide antibiotics 
[22] . It is possible, however, to test the effect of 
these macrolides in an indirect way, by their ability 
to compete effectively with chloramphenicol for 
binding to the ribosome. The inhibitory effect of 
chloramphenicol on the formation of acetyl-phenyl- 
alanylpuromycin by wild-type ribosomes from E. coli 
can be completely reversed by erythromycin [23]. 
Table 1 presents characteristics of the peptidyl 
transferase activity of mitochondrial ribosomes from 
D-6 and 6-8 1 c as assayed by a modified form of the 
fragment reaction, using acetyl 3H-leucyl-tRNA as 
substrate [17] . Data obtained with E. coli ribosomes 
are included for comparison. In agreement with the 
observations of De Vries, Agsteribbe and Kroon [ 171 
on the activity of mitochondrial ribosomes from 
Neurospora crassa in the fragment reaction, yeast 
mitochondrial ribosomes were highly sensitive to 
chloramphenicol, but only slightly affected by aniso- 
mycin, an inhibitor of peptidyl transferase activity of 
eukaryotic ribosomes. Wild-type ribosomes from 
strain D-6 resemble E. coli ribosomes in that inhibi- 
tion by chloramphenicol is completely reversed by 
erythromycin. In contrast, erythromycin cannot 
reverse the chloramphenicol inhibition with mutant 
ribosomes. 
Erythromycin alone markedly stimulated the 
fragment reaction by wild-type yeast ribosomes. This 
effect may result from an induced alteration in the 
ability of ribosomes to bind acetyl-leucyl-tRNA (cf. 
ref. [24]). It is of interest that significant stimulation 
is also observed with the ribosomes from the erythro- 
mycin-resistant strain 6-81~. This suggests .that ery- 
thromycin still binds to these ribosomes but not 
strongly enough to inhibit protein synthesis or prevent 
binding of chloramphenicol. 
Iincomycin inhibits the fragment reaction directly 
and this fact could be used to verify the cross-: 
resistance of the ribosomes to this antibiotic (table 1). 
Activity of ribosomes from the wild type, D-6, was 
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Table 1 
Antibiotic sensitivity of peptidyl transferase activity by mitochondrial and E. coli ribosomes. 
Additions or omissions 
Acetyl 3H-Leucyl-puromycin formed by ribosomes from 
D-6 6-81c E. coli 
Control 
Puromycin omitted 
Chloramphenicol67 #g/ml 
Anisomycin 27 pg/ml 
Erythromycin 6.7 @g/ml 
Erythromycin 13.3 &ml 
Chloramphenicol + erythromycin 6.7 &ml 
Chloramphenicol + erythromycin 13.3 Hg/ml 
Lincomycin 10e5 M 
Lincomycin lo4 M 
* Results of a single determination. 
100 100 100 
4 (2-6) 3 (2-4) 3 (1.5-4.5) 
7 (4- 10) 8 (5- 10) 18 (11-22) 
101* 93: 95 (91-97) 
163 (155-170) 124 (121-126) 109 (101-121) 
163 (160- 167) 134 (125-142) 99 (92-103) 
102 (100-103) 15 (10-20) 100 (91-107) 
100 (93-107) 15 (10-20) 107 (106- 107) 
10 (7-12) 71 (59-82) 40 (30-50) 
2* 46 (41-51) 10 (9-11) 
Peptidyl transferase activity was measured using acetyl-3H-leucyl tRNA as substrate. Values given are the mean (range) of two ex- 
periments with mitochondrial ribosomes and five experiments with E. coli ribosomes. Data have been corrected for blanks with- 
out ribosomes (107-126 cpm). In incubations with E. coli ribosomes approximately 60% of added acetyl-?-I-leucyl tRNA 
(22,000 dpm) was converted to acetyl-leucyl-puromycin. For mitochondrial ribosomes this value was approximately 50%. 
totally inhibited by 1 0e4 M lincomycin. In contrast, 
ribosomes from 6-81~ were only partially inhibited. 
antibiotics that act on the 50 S ribosomal subunit. 
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4. Discussion 
Our experiments clearly show that a cytoplasmic 
mutation involving resistance to erythromycin results, 
at least in this mutant, in a change in the mitochondrial 
ribosome. We are at present investigating the nature 
of the component responsible for resistance. Although 
it would be reasonable to assume that this component, 
as in many bacterial mutants examined [25,26] , is a 
protein of the large ribosomal subunit, we have not 
excluded the possibility that it is the ribosomal RNA 
which is changed (see [ 1 l] for discussion). 
Analysis of mutants was initially held up by our 
inability to find conditions that would allow the 
isolated mitochondrial ribosomes to effectively use 
mRNAs other than poly U. This complicated the 
analysis of resistance, because poly U-directed poly- 
phenylalanine synthesis is rather insensitive to many 
antibiotics of interest. The results presented here 
show that the fragment reaction provides a convenient 
way of overcoming this problem for erythromycin and 
chloramphenicol and it may also be useful with other 
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